Sun Pharmaceutical Q2 FY27 profit is 36.2% lower
Key Highlights
Sun Pharmaceutical reported a net profit of ₹1,995 crore for Q2 FY27. Revenue from operations for the quarter reached ₹16,199 crore.
Updated: Friday 30 October 2026
- Sun Pharmaceutical reported a net profit of ₹1,995 crore in Q2 FY27, 36.16% lower than a year earlier.
- from operations: ₹16,199 crore, 11.88% higher than a year earlier.
- Net profit margin: 12.32% (21.58% a year earlier).
- Shares: ₹1,777.70, +0.95% at 15:59 IST on 30 Oct 2026.
Sun Pharmaceutical Q2 FY27 results show a net profit of ₹1,995 crore, which is 36.16% lower than a year earlier. The company filed these financial results on 30 October 2026 at 2:14 pm IST.
Revenue from operations for the quarter stood at ₹16,199 crore. This figure is 11.88% higher than the revenue reported for the same quarter a year ago.
Sun Pharmaceutical Q2 FY27 results at a glance
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Q1 FY27 | Change |
|---|---|---|---|---|---|
| Revenue from operations | 16,199 | 14,478 | +11.88% | 15,300 | +5.87% |
| 3,153 | 4,155 | −24.13% | 4,089 | −22.90% | |
| Net profit | 1,995 | 3,125 | −36.16% | 2,901 | −31.23% |
| Earnings per share | ₹8.29 | ₹13.00 | −36.22% | ₹12.07 | −31.31% |
| Net profit as a share of revenue | 12.32% | 21.58% | – | 18.96% | – |
Sun Pharmaceutical reported a profit before tax of ₹3,153 crore for the quarter. The net profit margin reached 12.32% in Q2 FY27, compared to 21.58% in Q2 FY26 and 18.96% in Q1 FY27. For the half-year ending 30 September 2026, the company recorded a net profit of ₹4,896 crore, which is 9.63% lower than the same period a year earlier.
Sun Pharmaceutical half-year figures
| ₹ crore | Half-year | Same period a year earlier | Change |
|---|---|---|---|
| Revenue from operations | 31,499 | 28,330 | +11.19% |
| Net profit | 4,896 | 5,418 | −9.63% |
Sun Pharmaceutical share price after the results
| Share price (15:59 IST) | ₹1,777.70 |
| Previous close | ₹1,761.00 |
| Change | +₹16.70 (+0.95%) |
| Nifty Pharma | +1.55% |
| +0.51% |
The share price of Sun Pharmaceutical closed at ₹1,777.70 on 30 October 2026. This represents a move of 0.95% from the previous close of ₹1,761.00. The company filed its results at 14:14 IST during the trading session.
How Sun Pharmaceutical shares moved on its earlier results
| Quarter | Results filed | Window | Change |
|---|---|---|---|
| Q1 FY27 | 31 Jul 2026 | 30 Jul 2026 to 31 Jul 2026 | −0.53% |
| Q4 FY26 | 22 May 2026 | 21 May 2026 to 22 May 2026 | −2.47% |
Shares of Sun Pharmaceutical moved by −0.53% on the Q1 FY27 results. The stock price declined by 2.47% on the Q4 FY26 results.
Sun Pharmaceutical Q2 FY27 results: FAQs
What were Sun Pharmaceutical’s Q2 FY27 results?
Sun Pharmaceutical reported a net profit of ₹1,995 crore and revenue from operations of ₹16,199 crore for the quarter ended 30 September 2026 (consolidated figures). Net profit was 36.16% lower than a year earlier and revenue from operations was 11.88% higher than a year earlier.
When did Sun Pharmaceutical announce its Q2 FY27 results?
The results were filed with the exchange at Fri 30 Oct, 2:14 pm IST.
What was Sun Pharmaceutical’s net profit margin in Q2 FY27?
Net profit was 12.32% of revenue, against 21.58% in the same quarter a year earlier.
What is the Sun Pharmaceutical share price after the results?
₹1,777.70, +0.95% from the previous close of ₹1,761.00, at 15:59 IST on Friday 30 October 2026. The results were filed at 14:14 IST, during the session; the move is from the previous close, so it includes trading before the filing.
Results are the company’s filings to the exchanges; prices are from the National Stock Exchange. Calculations are by ThePip. For information only; not investment advice.